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US NEUROLOGY larger (4 ± 2 mm) in patients with cryptogenic cerebrovascular events than in controls (2 ± 1 mm) or in patients with strokes of a defined cause. 4 
Patent Foramen Ovale and Stroke
According to the World Health Organization (WHO), 15 million people suffer stroke worldwide each year. Of these, five million die while another five million are left permanently disabled. In the US, stroke is the third leading cause of death-with approximately 600,000 people experiencing stroke for the first time and an additional 185,000 experiencing recurrent stroke. As much as 40 % of these strokes cannot be identified as having any formative cause or factor, and therefore fall into the cryptogenic stroke category.
Even though the majority of ischemic strokes (85 %) occur in persons older than 65 years of age in tandem with development of atherosclerosis, a minority of ischemic strokes affects younger patients, to which as much as 43 % are cryptogenic. The most prevalent potential source of cardioembolism in young adults with cryptogenic stroke is PFO, which is detected in more than half of such persons. 5 Although there is a high prevalence of PFOs in young patients with cryptogenic stroke, Dr Kim and Dr Saver suggest that PFO itself is not necessarily a prediction of stroke risk. They state that young patients with the strongest potential for stroke are those who have PFO and atrial septal aneurysm. The risk for stroke in these patients is about 33 times higher than just PFO alone. Additional risks determined to affect the potential for stroke in young people include the size of PFO and the degree of functional shuntingparticularly patients with PFOs have greater right-to-left shunting (RLS) at rest compared with controls. The degree of RLS is related to not only PFO size, but also the presence of a prominent Eustachian valve that directs blood toward the PFO from the inferior vena. 6 The link between PFO and stroke remains evident as it continues to be The primary end point of this study failed to show a significant benefit to PFO closure an adults with cryptogenic stroke, yet they concluded that PFO closure was more beneficial than medical therapy in the prevention of recurrent neurological events. 7 These data further support the role PFO has in the increased risk for stroke and the importance of closure once detected.
The Risk of Paradoxical Embolism (RoPE) meta-analysis study created an 11-point scoring system where 1 point (each factor) is given if a patient lacks a history of hypertension, diabetes, stroke/TIA or is a nonsmoker, or has a cortical infarct on imaging. These factors therefore can combine for a score ranging from 0 to 5. In addition, points are added based upon age: 18-29 (5 points); 30-39 (4 points); 40-49 (3 points); 50-59 (2 points); 60-69 (1 point); >70 (0 point). Using this scoring system the PFO prevalence was 23 % if the RoPE score was 0-3 and increased linearly to a PFO prevalence of 73 % if the RoPE score was 9-10. This scoring system has been useful in estimating the general PFO prevalence in a population, which can become useful in determining the patient selection for potential PFO closure. 8 
Patent Foramen Ovale and Migraine
The relationship between migraine and PFO continues to undergo research. Although data have yielded mixed results, there appears to be some evidence that PFO affects the presence of migraine when accompanied by aura. A study has shown that those who suffer migraine with an aura beforehand were twice as likely to have a PFO (41-48 %)
than the general population. 9 A 2003 study assessed the prevalence of migraine in a large patient population with a presumed PFO-mediated paradoxical embolism. The results, derived between 1998 and 2002,
of 215 subjects had a demonstrated prevalence of headache of 33 % prior to PFO closure, which was reduced by 54 % in patients with migraine with aura, and by 62 % in patients with migraine without aura. 10 The study demonstrated that patients with a presumed PFO were twice as likely to have migraine with aura over the general population and that PFO closure reduced the frequency of migraine attacks both with and without aura. Of all the patients, 8.5 %, of which 11 % had migraines accompanied by aura, had complete migraine remission. 12 Although an established pathway has not been identified between PFO and migraine, it appears that in some cases, especially those where migraine includes aura, PFO closure may positively affect frequency and duration.
Patent Foramen Ovale and Sleep Apnea
Obstructive sleep apnea (OSA) is a common disorder affecting 24 % and 9 % of middle-aged men and women. OSA constitutes a major public health concern because of its prevalence among cardiovascular complications such as hypertension, ischemic heart disease, heart failure, stroke, pulmonary hypertension, and a variety of cardiac arrhythmias. PFO was related to an absolute risk for five major DCI events per 10,000; five times higher than those without a PFO. 15 
Patent Foramen Ovale and Dementia
In the US alone, 4.5 million people have been diagnosed with some degree of dementia. Purandare found that spontaneous cerebral emboli was present in 40 % of patients with Alzheimer's and nearly 37 % of Alzheimer's have a PFO. 16 Purandare also explored the role of paradoxical embolization in dementia by investigating cerebral emboli, venous to arterial circulation shunts, and carotid artery disease. The results of the study showed that cerebral emboli were detected in 27 % of dementia patients compared with 7 % in the control group. In the dementia patients with cerebral emboli, a venous to arterial shunt was detected in 64 % and moderate to severe carotid stenosis was present in 30 %. 17 These data confirm paradoxical embolization as a potential mechanism for cerebral damage, influencing vascular dementia and Alzheimer's disease. The prominence of PFO as a contributing factor in the occurrence of VAE was discussed by Mirski et al. who reported that PFO has been found to permit air directly into cerebral circulation and that patients with documented PFO appear to be at increased risk for paradoxical embolus during surgery. 20 They also pointed out that early detection of PFO is the best prevention of such an event.
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Testing Methods
Currently there are several accepted practices being utilized in PFO
detection, yet most of them were not specifically designed for such.
Consequently, there is widespread variance in confidence levels among the results presented in some of these methods. Limitations in sensitivity, specificity, and quantification pose the biggest concerns that need to be addressed.
Transesophageal Echocardiography
TEE is considered the "gold standard" in screening because it is perceived to be the superior method of testing. TEE is an invasive procedure that shows 2D ultrasound imaging of the heart from a transesophageal approach. It displays the anatomy and (with great variability from patient to patient), and that understanding these limitations should be evaluated before scheduling a patient for PFO closure. 22 
Transthoracic Echo
Transthoracic echo (TTE) is frequently used as a "first line" method of PFO assessment due to its economic value, and it is minimally invasive.
An ultrasound probe is placed over the patient's chest, and like TEE, visualizes the heart's anatomy. This imaging is performed in conjunction with a contrast intravenous injection-agitated saline (bubble study). Since the patient does not require sedation, it is possible to obtain a voluntary Valsalva maneuver. However, obesity, chronic lung disease, and even the Valsalva maneuver itself often present significant obstacles in obtaining adequate visualization of the atria through the chest wall due to the depth or the presence of lung tissue.
Even though TEE is the most popular of all three screening methods, it has the lowest sensitivity. One study compared 19 known patients with a known PFO. The TEE was only able to detect nine out of 19 (47 %) patients.
The study concluded that the sensitivity of transthoracic echocardiography is heavily hampered by the frequency of inadequate heart visualization. 23 
Transcranial Doppler
Transcranial Doppler (TCD) is an alternative method for indirectly diagnosing intracardiac RLS by detecting air or contrast microbubbles passing through the intracranial arteries, with insonation of at least one middle cerebral artery (MCA). Shunt conductance is graded by a logarithmic scale (1-3) with 3 being used as a cutoff for a positive study.
Even though TCD has been shown to have high sensitivity and is more comfortable for the patient, TCD cannot localize the site of the RLS or determine its size. Therefore, TCD is recommended as a complementary procedure to TEE, to increase diagnostic accuracy in detecting PFO but not as a stand-alone procedure. 24 
Ear Oximetry
First suggested by Karltunen et al., 25 pulse oximetry (SpO 2 ) via an ear sensor has been utilized for RLS screening through the detection of an oxygen desaturation response following repetitive Valsalva procedures.
In a recent study of 165 scuba divers utilizing this technique with a threshold of >0.825 SpO 2 change resulted in a sensitivity of 0.756 and a specificity of 0.706. 26 This technique has the potential for use as a screening tool for large populations at a very low cost. SpO 2 , device time averaging, motion artifact, and venous blood induced changes in SpO 2 may limit further improvement on these detection parameters. A study conducted in Finland, 2001, determined that there was an identifiable need for a low-cost, noninvasive method for detecting PFO. The study compared the accuracy of dye dilution curves with oximetry against contrast TEE. They concluded that dye dilution and oximetry are both sensitive and specific methods of detecting RLS. Furthermore, oximetry was primarily advantageous over the current diagnostic methods as it was noninvasive, safe, and inexpensive with no discomfort to the patient.
The team suggested that oximetry could be used as a first-line screening method for PFO in patients with cryptogenic stroke. 27 
Dye Dilution Curves
Indicator dye dilution curves and ear oximetry were first used in the late 1950s when Carter, Swan, and Wood injected Evans blue dye into the superior vena cava and pulmonary arteries to determine that time and concentration were critical values in determining abnormal dilution curves. glottis. Simple blowing into a manometric device with a closed glottis using air only in the pharynx and cheeks will not be effective in creating an increase in intrathoracic pressure. 31 The results of a Valsalva simulation (see Figure 1 ) 31 Valsalva recommended that airway pressure be held at 40 mmHg for a minimum of 10 seconds and then abruptly released. 32 Specific changes in blood pressure, rate, and volume of venous blood returning to the heart both during and after the maneuver provide invaluable data that can be used in determining size and extent of a PFO. The timing of administration of the contrast agent (microbubbles in saline or saline/blood mixture or dye) with the Valsalva release is also important to properly control so that the contrast agent will be available within the right atrium at the time of the temporary opening of the PFO (Figure 3) . 33 A study conducted in 2013 evaluated the relevance of a performed Study" focuses on the number of bubbles seen in a single still frame within the left atrium. The more bubbles that pass through to the LA, presumably, the larger the shunt is (see Table 1 ).
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Transcranial Doppler-Embolic Strikes
The Spencer algorithm is a method of grading PFO presence while using the TCD method of sonographic imaging. In this grading scale, a contrast agent is injected and embolic tracks or strikes are measured and recorded when they pass through to the left atrium. Again, the greater the number of bubbles passing through, the greater the perceived significance of a PFO (see Table 2 ).
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ICG Dye Dilution Curves-Peak Spectral Analysis
With the ICG Dye Dilution curve method of assessing PFO, ICG dye is injected and its appearance rate at the site of the ear is monitored for one or two peaks. One peak indicates no shunting, while two peaks suggest that a portion of dye found a secondary pathway (shunt) that avoided traversing the pulmonary system.
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Conclusion
The established correlation between PFO and a series of clinical manifestations such as stroke/TIA, migraine, OSA, DCI, and others has been documented in a multitude of studies and reports. PFO may be a significant health factor and PFO status should be considered as a potential contributing etiology for these conditions when developing a diagnosis and treatment plan. 
